Healthcare News

FDA clears DNA test to spot cancer genes, but with warnings

Written by David Miller

The Food and Drug Administration has approved the first direct-to-consumer breast cancer gene test, but it will require 23andMe to warn consumers about the limitations of the genetic information.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]